Athelas
Athelas provides AI-powered healthcare technology, including Revenue Cycle Management, an AI Scribe, and remote patient monitoring for vitals.
Secondary Market Price
How Athelas Measures Up
To help you manage your Athelas equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
TBD
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Athelas's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Athelas Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Athelas's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Athelas provides AI-driven technology for healthcare organizations, focusing on administrative and clinical tasks. The company's offerings include a Revenue Cycle Management (RCM) platform for medical billing and payments, an Electronic Health Record (EHR) system with ambient AI features for automating documentation, and Remote Patient Monitoring (RPM) services. The RPM service uses devices like blood pressure cuffs and glucometers to allow providers to track patient vitals remotely. Founded in 2016 by Tanay Tandon and Deepika Bodapati, the company is headquartered in Mountain View, California.
Recent activity for Athelas includes bringing on new clients such as MAXX Physical Therapy and GI Partners of Illinois, who use the platform for operational and revenue improvements. The company states it is used by over 500,000 providers. In March 2022, Athelas raised $59.4 million in a Series C funding round, and its last known valuation was reported at $1.5 billion. Company personnel and partners have recently appeared on podcasts to discuss topics like clinical analytics in orthopedics and scaling systems in physical therapy.
- General Catalyst
- Tribe Capital
- Sequoia Capital
- Y Combinator
- Greenoaks
- Human Capital
- Initialized Capital
- Co-Founder, Tanay Tandon
- Co-Founder, Deepika Bodapati
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Athelas worth joining?
Deciding to join Athelas involves assessing its growth prospects and how its equity package compares to other opportunities. Tools like Prospect can help you evaluate the potential value of your equity offer by using data-driven models to project the company's future outcomes.
What should I do with my Athelas stock?
The best strategy for your Athelas stock depends on your financial goals, tax situation, and the company's performance. Prospect offers personalized option exercise and stock sale strategies to help you maximize your equity's value and minimize your tax burden.
Can you sell Athelas stock?
As a private company, selling Athelas stock is generally restricted to specific liquidity events like tender offers or secondary market sales. When such opportunities arise, platforms like Prospect provide tools to help you decide how much to sell and which shares are most tax-optimal.
How can I find the value of my Athelas stock?
Since Athelas is a private company, its stock value is not publicly listed and is typically estimated based on internal valuations or recent funding rounds. You can get a more data-driven estimate by using Prospect, which uses proprietary models to project your equity's potential future value.
What is Athelas's equity worth?
The total worth of Athelas's equity is tied to the company's overall valuation, which can fluctuate based on performance, funding, and market conditions. To understand the potential worth of your specific holdings, Prospect provides predictive models and scenario analysis to help you evaluate a range of possible outcomes.
What is Athelas's stock ticker symbol?
Athelas does not have a stock ticker symbol because it is a private company and its shares are not traded on a public stock exchange. Ticker symbols are only assigned to companies after they complete an Initial Public Offering (IPO).
Can I buy or sell Athelas stock?
For employees, "buying" Athelas stock typically means exercising your stock options, while selling is limited to specific company-approved events. Prospect can help you create a tax-efficient strategy for both exercising your options and selling your shares when the time is right.
What is the criteria to buy or invest in Athelas stock?
Investing directly in Athelas as an outside investor is usually restricted to accredited investors during formal funding rounds. For employees, the primary way to acquire stock is by exercising vested options granted as part of your compensation package.
